An Open Label Phase 1, Randomized Cross Over Trial To Estimate The Effect Of PF- 00299804 On The Pharmacokinetics Of Dextromethorphan In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 12 Jul 2012
At a glance
- Drugs Dacomitinib (Primary) ; Dextromethorphan
- Indications Head and neck cancer; Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Pfizer
- 08 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Nov 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 02 Nov 2009 New trial record